PetMed Express, Inc. cash flow to debt ratio of -5.31K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

PetMed Express, Inc.'s free cash flow has decreased 8.26K% from $-395.00K last year to $-33.01M, signaling decreasing performance

PetMed Express, Inc.'s debt to equity ratio is 0.02, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.

PetMed Express, Inc.'s debt has increased relative to shareholder equity from 0.01 last year to 0.02 today, signaling weakened financials

PetMed Express, Inc. has negative EBITDA, making leverage ratio unreliable

PetMed Express, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

PetMed Express, Inc.'s profit margin has decreased (1.06K%) in the last year from -2.76% to -32.00%, signaling decreasing performance

PetMed Express, Inc.'s short-term liabilities of $52.03M exceed its short-term assets of $43.56M, signaling financial risk

PetMed Express, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

PetMed Express, Inc.'s return on equity of -146.59%, is lower than 15.00%, indicating bad performance

PetMed Express, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

PetMed Express, Inc. had positive net income in only 2.00 out of 5 years, indicating unstable earnings

PetMed Express, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

PetMed Express, Inc. has negative free cash flow, indicating cash burn

PetMed Express, Inc.'s yearly earnings has decreased 813.51% since last year from $-6.27M to $-57.29M, signaling decreasing performance

PetMed Express, Inc.'s yearly revenue has decreased -21.13% since last year from $226.97M to $179.02M, signaling decreasing performance

ROIC -105.82% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

PetMed Express, Inc.'s 3-year revenue CAGR of -11.31% is negative, indicating declining revenue over the past 3 years

PetMed Express, Inc. had revenue growth in only 1.00 out of 5 years, indicating inconsistent revenue performance

PetMed Express, Inc. had positive ROE in only 2.00 out of 5 years, indicating inconsistent returns on equity

PetMed Express, Inc. has insufficient data to evaluate this check.

PetMed Express, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

PetMed Express, Inc. is undervalued relative to its fair value price of 4.71 based on EBITDA multiple model

PetMed Express, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

PetMed Express, Inc. is overvalued relative to its fair value price of -0.39 based on Earnings Fair Value model

PetMed Express, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

PetMed Express, Inc. has a price-to-book ratio of 1.42x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

PetMed Express, Inc. has a price-to-sales ratio of 0.23x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue